domingo, 23 de febrero de 2025

FDA Approves First Treatment for Cerebrotendinous Xanthomatosis, a Rare Lipid Storage Disease

https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-cerebrotendinous-xanthomatosis-rare-lipid-storage-disease?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario